These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29540859)

  • 1. SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition.
    Lopez-Sanz L; Bernal S; Recio C; Lazaro I; Oguiza A; Melgar A; Jimenez-Castilla L; Egido J; Gomez-Guerrero C
    Lab Invest; 2018 Oct; 98(10):1276-1290. PubMed ID: 29540859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.
    Recio C; Lazaro I; Oguiza A; Lopez-Sanz L; Bernal S; Blanco J; Egido J; Gomez-Guerrero C
    J Am Soc Nephrol; 2017 Feb; 28(2):575-585. PubMed ID: 27609616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
    Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressors of cytokine signaling abrogate diabetic nephropathy.
    Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
    J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in diabetic nephropathy.
    Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
    Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS1 Peptidomimetic Alleviates Glomerular Inflammation in MsPGN by Inhibiting Macrophage M1 Polarization.
    Zhao Y; Peng F; He J; Qu Y; Ni H; Wu L; Chen X
    Inflammation; 2023 Dec; 46(6):2402-2414. PubMed ID: 37581761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinomenine improve diabetic nephropathy by inhibiting fibrosis and regulating the JAK2/STAT3/SOCS1 pathway in streptozotocin-induced diabetic rats.
    Zhu M; Wang H; Chen J; Zhu H
    Life Sci; 2021 Jan; 265():118855. PubMed ID: 33278392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant Effects of PS5, a Peptidomimetic of Suppressor of Cytokine Signaling 1, in Experimental Atherosclerosis.
    La Manna S; Lopez-Sanz L; Bernal S; Jimenez-Castilla L; Prieto I; Morelli G; Gomez-Guerrero C; Marasco D
    Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32824091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease.
    Prieto I; Kavanagh M; Jimenez-Castilla L; Pardines M; Lazaro I; Herrero Del Real I; Flores-Muñoz M; Egido J; Lopez-Franco O; Gomez-Guerrero C
    Mol Ther Nucleic Acids; 2023 Dec; 34():102041. PubMed ID: 37842165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway.
    Chen Y; Chen L; Yang T
    Life Sci; 2021 Apr; 271():119197. PubMed ID: 33577847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danzhi Jiangtang Capsule ameliorates kidney injury via inhibition of the JAK-STAT signaling pathway and increased antioxidant capacity in STZ-induced diabetic nephropathy rats.
    Sun M; Bu W; Li Y; Zhu J; Zhao J; Zhang P; Gu L; Zhang W; Fang Z
    Biosci Trends; 2019 Jan; 12(6):595-604. PubMed ID: 30606979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes.
    Opazo-Ríos L; Sanchez Matus Y; Rodrigues-Díez RR; Carpio D; Droguett A; Egido J; Gomez-Guerrero C; Mezzano S
    BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32900697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
    Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
    Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy.
    Shi Y; Du C; Zhang Y; Ren Y; Hao J; Zhao S; Yao F; Duan H
    Am J Nephrol; 2010; 31(5):380-8. PubMed ID: 20299783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and Kidney Disease: Role of Oxidative Stress.
    Jha JC; Banal C; Chow BS; Cooper ME; Jandeleit-Dahm K
    Antioxid Redox Signal; 2016 Oct; 25(12):657-684. PubMed ID: 26906673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
    Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
    Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
    Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidation and Nrf2-mediated heme oxygenase-1 activation contribute to renal protective effects of hydralazine in diabetic nephropathy.
    Chang TT; Chiang CH; Chen C; Lin SC; Lee HJ; Chen JW
    Biomed Pharmacother; 2022 Jul; 151():113139. PubMed ID: 35623171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.